Clinics in Dermatology
Volume 27, Issue 4 , Pages 350-354 , July 2009

Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care

  • Brett M. Coldiron, MD

      Affiliations

    • Department of Dermatology, University of Cincinnati College of Medicine, 3024 Burnet Avenue, Cincinnati, OH 45219, USA
    • ,
  • Scott Dinehart, MD

      Affiliations

    • Department of Dermatology, University of Arkansas School of Medicine, 6901 Lile Drive, Little Rock, AR 72205, USA
    • ,
  • Howard W. Rogers, MD

      Affiliations

    • Advanced Dermatology, LLC, 111 Salem Turnpike, Suite 7 Norwich, CT 06360, USA
    • Corresponding Author InformationCorresponding author.

References 

  1. Rubenfeld GD, McNamara-Aslin E, Rubinson L. The pulmonary artery catheter, 1967-2007: rest in peace?. JAMA. 2007;298:458–461
  2. Handley WS. In: The genesis of cancer. London: Paul, Trench, Trubner; 1931;p. 222
  3. Snow H. Melanotic cancerous disease. Lancet. 1892;ii:872–874
  4. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol. 1988;6:163–172
  5. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med. 1977;297:627–630
  6. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793–796
  7. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61:697–705
  8. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255–263[discussion 263-6]
  9. Silberman AW. Malignant melanoma. Practical considerations concerning prophylactic regional lymph node dissection. Ann Surg. 1987;206:206–209
  10. Slingluff CL, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg. 1994;219:120–130
  11. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999;230:453–463[discussion 463-5]
  12. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759–767
  13. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol. 2001;8(9 Suppl):44S–47S
  14. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976–983
  15. McMasters KM, Sondak VK, Lotze MT, Ross MI. Recent advances in melanoma staging and therapy. Ann Surg Oncol. 1999;6:467–475
  16. Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88:1484–1491
  17. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634
  18. Ferrone CR, Panageas KS, Busam K, Brady MS, Coit DG. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol. 2002;9:637–645
  19. Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Ann Surg Oncol. 2007;14:1604–1611
  20. Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol. 2003;21:1057–1065
  21. Wagner JD, Ranieri J, Evdokimow DZ, et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg. 2003;112:486–497
  22. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134:381–387
  23. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008;5:18–23
  24. van Akkooi AC, de Wilt JH, Voit C, Verhoef C, Suciu S, Eggermont AM. Sentinel lymph-node false positivity in melanoma. Nat Clin Pract Oncol. 2008;5:E2
  25. Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol. 2006;13:809–816
  26. Morton DL, Cochran AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol. 2004;151:308–319
  27. Yan S, Brennick JB. False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am J Surg Pathol. 2004;28:596–600
  28. Holt JB, Sangueza OP, Levine EA, et al. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am J Clin Pathol. 2004;121:58–63
  29. Starz H, Haas CJ, Schulz GM, Balda BR. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes. Mod Pathol. 2003;16:920–929
  30. Biddle DA, Evans HL, Kemp BL, et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol. 2003;27:673–681
  31. Davids V, Kidson SH, Hanekom GS. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol. 2003;56:43–51
  32. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317
  33. van Akkooi AC, Bouwhuis MG, de Wilt JH, Kliffen M, Schmitz PI, Eggermont AM. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg. 2007;94:1293–1299
  34. Tanis PJ, Nieweg OE, van den Brekel MW, Balm AJ. Dilemma of clinically node-negative head and neck melanoma: outcome of “watch and wait” policy, elective lymph node dissection, and sentinel node biopsy-A systematic review. Head Neck. 2008;30:380–389
  35. Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Ann Surg Oncol. 2007;14:3566–3574
  36. Gutzmer R, Al Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol. 2005;153:1137–1141
  37. González U. Cloud over sentinel node biopsy: unlikely survival benefit in melanoma. Arch Dermatol. 2007;143:775–776
  38. Sondak VK, Zager JS, Messina JL, Thomas JM. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol. 2007;5:483–490
  39. Kretschmer L, Hilgers R. Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma. J Clin Oncol. 2006;24:2965–2966
  40. Henderson MA. Completion lymphadenectomy for melanoma patients with a positive sentinel node biopsy remains standard of care. Ann Surg Oncol. 2006;13:761–763
  41. National Comprehensive Cancer Network . Melanoma guides. Available at http://www.nccn.org
  42. Cohen MH. Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation. Dermatol Ther. 2003;16:77–84
  43. Tsai KY. Systemic adjuvant therapy for patients with high-risk melanoma. Arch Dermatol. 2007;143:779–782
  44. Stephanie G, Benedetti J, Crowley J. Clinical trials in oncology. 2nd ed.. Boca Raton (FL): CRC Press; 2003;

PII: S0738-081X(09)00026-1

doi: 10.1016/j.clindermatol.2009.02.006

Clinics in Dermatology
Volume 27, Issue 4 , Pages 350-354 , July 2009

Article Tools

* Image Usage & Resolution